Fundraising FoxPavilion Capital — 2019 Investments
4 investments dated 2019 · listed companies and verified rows first · show all
Insilico Medicine uses artificial intelligence to discover and develop new drugs, operating an AI-driven platform for pharmaceutical research and development.
AI & Machine LearningBiotechDigital HealthHealthtechHong Kong, US
Aleksandrs Zavoronkovs(Executive Officer, Director)Alex Zavoronkov(Director)Alex Zhavoronkov(Founder)inAlex Aliper(President)inFeng Ren(Chief Scientific Officer, Executive Director & Co-CEO)in
BoardNisa Leung(Director)in
Co-investorsLilly Asia VenturesOrbiMedQiming Venture PartnersWarburg PincusBaidu VenturesEight Roads Ventures+15 more
Readcoor developed an in situ spatial transcriptomics platform using padlock probe rolling circle amplification chemistry to detect and map RNA transcripts across tissue sections, now offered as the Xenium In Situ platform.
BiotechDeep TechHardwareHealthtechCambridge, US
Evan Daugharthy(Cofounder)Richard Terry(Executive Officer, Director)
BoardYuh-Geng Tsay(Director)Victor Tong(Director)Thomas Grogan(Director)
Co-investorsDecheng CapitalLAVLilly Asia VenturesLilly VenturesVivo Capital
Omnichannel beauty and personal care retail and distribution platform in Indonesia.
Chrisanti Indiana(Founder)inChristopher Madiam(Founder)John Marco Rasjid(Founder)John Rasjid(Founder)
Co-investorsEast VenturesGeneral AtlanticJungle VenturesVenturraL CattertonTemasek
Travelio appears to operate a property rental and accommodation booking service in Indonesia, based on a booking modification and refund policy notice.
MarketplacesPropTechTravel & Hospitality
Christina Suriadjaja(Founder)in
Co-investors500 GlobalAppWorks VenturesGobi PartnersIndogen CapitalInsignia Ventures PartnersVynn Capital+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.